4th Annual Biosimilars Summit

The Vonlanthen Group of Companies is pleased to invite you to the 4th Annual Biosimilars Summit scheduled for June 7 -8, 2018 in Vienna, Austria.

This 4th Annual Summit brings together industry leaders to discuss the current developments in Biosimilars. Throughout the two day summit, experts will explore strategies and gain insights into designing new Biosimilar development programs; the analysis methods, clinical advancements, and new solutions for successful implementation in the market.

It is an interactive environment conducive to impactful networking opportunities, learning best practices, maintaining business relationships, and meeting new clients.

We look forward to welcoming you at the Summit in Vienna!

Key Practical Learning Points of the Summit:

  • US long-waited guidelines for interchangeability
  • Latest achievements in Biosimilars in therapeutic areas
  • Innovations in clinical trials
  • Clinical case studies
  • Extrapolation and interchangeability
  • Demonstrating interchangeability
  • Biobetters: Opportunities in development
  • Legal considerations for Biosimilars
  • Successful commercialisation of Biosimilars in Europe, USA and emerging markets
  • Pricing & reimbursement

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Lab Heads, Leaders and Managers specialising in:

  • Biologics/Biotechnology/ Biogenerics
  • Biopharmaceuticals
  • Legal Affairs
  • Intellectual Property
  • Pricing and Reimbursement
  • Clinical Immunology
  • Regulatory Compliance
  • R&D
  • Preclinical and Clinical Development
  • New Product Development
  • Quality Affairs/ Quality Control
  • Pharmacovigilance


  • Clinical Immunology
  • Oncology
  • Immunology
  • Infection and Immunity
  • Drug Safety
  • Risk Management
  • Preclinical Development
  • Clinical Program
  • Therapeutic Areas
  • Personalised Medicine
  • Business Development
  • Portfolio Planning
  • Vaccines Development
  • Regulatory Affairs
  • Scientific Affairs
  • Pharmacovigilance
  • Validation
  • Global Strategy
  • Analytical Characterisation
  • Antibody Engineering
  • Antibody Discovery
  • Formulation Development
  • Outsourcing